Michael A. Posternak, MD

Original Research

Response Rates to Fluoxetine in Subjects Who Initially Show No Improvement

May 31, 2011

Original Research

Developing Brief Scales for Use in Clinical Practice: The Reliability and Validity of Single-Item Self-Report Measures of Depression Symptom Severity, Psychosocial Impairment Due to Depression, and Quality of Life

October 16, 2006

Original Research

Prevalence and Features of Intermittent Explosive Disorder in a Clinical Setting

October 14, 2005

Letter to the Editor

"Reply to Weight Gain, Sexual Dysfunction and Buropion."

October 14, 2005

Original Research

Differences Between Minimally Depressed Patients Who Do and Do Not Consider Themselves to Be in Remission

September 15, 2005

Letter to the Editor

Reply to "Accurate Meta-Analytical Assesment of "True Antidepressants Effects"

September 15, 2005

Original Research

Dual Reuptake Inhibitors Incur Lower Rates of Tachyphylaxis Than Selective Serotonin Reuptake Inhibitors: A Retrospective Study

June 15, 2005

Original Research

Why Isn't Bupropion the Most Frequently Prescribed Antidepressant?

May 15, 2005

Original Research

Tachyphylaxis in Unipolar Major Depressive Disorder

March 15, 2005

Original Research

Is There a Delay in the Antidepressant Effect? A Meta-Analysis

February 15, 2005

Commentary

Using Questionnaires to Screen for Psychiatric Disorders: A Comment on a Study of Screening for Bipolar Disorder in the Community

May 1, 2004

Original Research

Defining Remission on the Montgomery-Asberg Depression Rating Scale

February 1, 2004